Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Oncothyreon Inc

+ Add to Watchlist


3.0100 USD 0.5000 19.92%

As of 20:10:00 ET on 05/22/2015.

Company Profile for Oncothyreon Inc (ONTY)

Oncothyreon, Inc. develops therapeutic approaches to cancer management. The Company focuses on the development of synthetic vaccines and strategies for immunotherapy of cancer. Oncothyreon delivers its services to customers throughout the United States.

Contact Information

Oncothyreon Inc

2601 Fourth Avenue
Suite 500
Seattle, WA 98121
United States
Phone: 1-206-801-2100
Fax: 1-206-801-2101

Key Executives for Oncothyreon Inc (ONTY)

Robert L KirkmanPresident/CEOGary ChristiansonChief Operating Officer
Diana HausmanChief Medical OfficerScott PetersonChief Scientific Officer
Julia M EastlandVP:Corporate Dev/CFO/SecyJane TullochDirector:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil